Mice severely disabled by a multiple sclerosis (MS) – like condition could walk less than two weeks following treatment with human stem cells.
The finding, which uncovers new avenues for treating MS, will be published online on May 15, 2014, in the journal Stem Cell Reports.
When scientists transplanted human stem cells into MS mice, they predicted the cells would be rejected, much like rejection of an organ transplant.
Expecting no benefit to the mice, they were surprised when the experiment yielded spectacular results.
“My postdoctoral fellow Dr. Lu Chen came to me and said, ‘The mice are walking.’ I didn’t believe her,” said co-senior author, Tom Lane, Ph.D., a professor of pathology at the University of Utah, who began the work at University of California, Irvine.
Within just 10 to 14 days, the mice regained motor skills. Six months later, they still showed no signs of slowing down.
“This result opens up a whole new area of research for us,” said co-senior author Jeanne Loring, Ph.D., co-senior author and professor at The Scripps Research Institute in La Jolla, Calif.
More than 2.3 million people worldwide have MS, a disease where the immune system attacks myelin, an insulation layer surrounding nerve fibers. The resulting damage inhibits nerve impulses, producing symptoms that include difficulty walking, impaired vision, fatigue and pain.
The MS mice treated with human stem cells experience a reversal of symptoms. Immune attacks are blunted, and damaged myelin is repaired, explaining their dramatic recovery. The discovery could help patients with latter, or progressive, stages of the disease, for whom there are no treatments.
Counterintuitively, the researchers’ original prediction that the mice would reject the stem cells, came true. There are no signs of the cells after one week. In that short window, they send chemical signals that instruct the mouse’s own cells to repair the damage caused by MS. This realization could be important for therapy development.
“Rather than having to engraft stem cells into a patient, which can be challenging, we might be able to put those chemical signals into a drug that can be used to deliver the therapy much more easily,” said Lane.
With clinical trials as the long-term goal, the next steps are to assess durability and safety of the stem cell therapy in mice.
“I would love to see something that could promote repair and ease the burden that patients with MS have,” said Lane.
“This result opens up a whole new area of research for us,” said co-senior author Jeanne Loring, Ph.D., co-senior author and professor at The Scripps Research Institute in La Jolla, Calif.
More than 2.3 million people worldwide have MS, a disease where the immune system attacks myelin, an insulation layer surrounding nerve fibers. The resulting damage inhibits nerve impulses, producing symptoms that include difficulty walking, impaired vision, fatigue and pain.
The MS mice treated with human stem cells experience a reversal of symptoms. Immune attacks are blunted, and damaged myelin is repaired, explaining their dramatic recovery. The discovery could help patients with latter, or progressive, stages of the disease, for whom there are no treatments.
Counterintuitively, the researchers’ original prediction that the mice would reject the stem cells, came true. There are no signs of the cells after one week. In that short window, they send chemical signals that instruct the mouse’s own cells to repair the damage caused by MS. This realization could be important for therapy development.
“Rather than having to engraft stem cells into a patient, which can be challenging, we might be able to put those chemical signals into a drug that can be used to deliver the therapy much more easily,” said Lane.
With clinical trials as the long-term goal, the next steps are to assess the durability and safety of the stem cell therapy in mice.
“I would love to see something that could promote repair and ease the burden that patients with MS have,” said Lane.
The Latest on: Human Stem Cell Treatment
[google_news title=”” keyword=”Human Stem Cell Treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Human Stem Cell Treatment
- Stem Cell Therapy Improves Post-Stroke Motor Functionon May 7, 2024 at 5:00 pm
CHICAGO — Early results from a first-in-human trial some 20 years in the making suggest that neural stem cell transplantation is safe and improves motor function starting at 1 month after treatment in ...
- Toward Ageless Muscles: The Stem Cell Solutionon May 2, 2024 at 10:45 am
While stem cell therapy may seem like a perfect solution ... To overcome these limitations, the researchers set out to study how lab-grown human stem cells behave once transplanted into mice.
- Preclinical study finds novel stem cell therapy boosts neural repair after cardiac arreston May 1, 2024 at 10:13 am
Researchers at the University of Maryland School of Medicine (UMSOM) have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model.
- Characterizing Human Stem Cell-Derived Disease Models with Microelectrode Arrayson April 30, 2024 at 7:23 am
Drug development for the treatment of amyloid lateral sclerosis (ALS) requires an understanding of how genetic mutations lead to the ALS phenotype. Researchers use human induced pluripotent stem cell ...
- Celebrities investing in anti-aging stem cell treatments despite side effectson April 28, 2024 at 5:16 am
John Cleese, the acclaimed British actor and comedian, publicly disclosed his use of experimental anti-aging treatments. In an interview with Saga Magazine, the 84-year-old Monty Python co-creator ...
- Using stem cell-derived heart muscle cells to advance heart regenerative therapyon April 26, 2024 at 6:01 am
Study shows that cardiac spheroids, derived from human induced pluripotent stem ... after cell transplantation and will greatly accelerate the realization of cardiac regenerative therapy ...
- John Cleese is spending thousands on stem cell therapy – is it really the secret to anti-ageing?on April 24, 2024 at 10:00 pm
Monty Python’ star John Cleese has revealed that he has been having stem cell treatment for decades in a bid to slow down the ageing process. Katie Rosseinsky asks the experts whether this therapy is ...
- Alzheimer’s trial doses patients with stem cell treatment directly to brainon April 24, 2024 at 11:23 am
California-based Regeneration Biomedical has dosed the first patient has been dosed in a first-in-human trial of its autologous stem cell treatment, RB-ADSC, for patients with mild-to-moderate ...
- Stem cell treatment for brain diseases praisedon April 18, 2024 at 5:00 pm
British scientists today welcomed research by their US counterparts into developing stem cell treatments for devastating ... A spokesman for the Human Fertilisation and Embryology Authority ...
- This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Marketon April 10, 2024 at 6:00 am
The goal of their startup, Somite.ai, is to improve the lives of millions of people by leveraging AI to produce human tissue for ... mix of state-of-the art stem cell biology, medicine, genetics ...
via Bing News